Fig. 2From: Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic reviewCumulative frequency curve of atypical femoral fracture events in patients with bone metastasis receiving denosumab 120âmg monthlyBack to article page